RGBP
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jul 2 closing price
Capitalization
1.13M
ROIV
Price
$10.99
Change
+$0.02 (+0.18%)
Updated
Jul 3, 02:00 PM (EDT)
Capitalization
7.44B
46 days until earnings call
Interact to see
Advertisement

RGBP vs ROIV

Header iconRGBP vs ROIV Comparison
Open Charts RGBP vs ROIVBanner chart's image
Regen Biopharma
Price$0.05
Change-$0.00 (-0.00%)
Volume$5.23K
Capitalization1.13M
Roivant Sciences
Price$10.99
Change+$0.02 (+0.18%)
Volume$430.58K
Capitalization7.44B
RGBP vs ROIV Comparison Chart in %
Loading...
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RGBP vs. ROIV commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGBP is a Hold and ROIV is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (RGBP: $0.05 vs. ROIV: $10.97)
Brand notoriety: RGBP and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RGBP: 31% vs. ROIV: 174%
Market capitalization -- RGBP: $1.13M vs. ROIV: $7.44B
RGBP [@Biotechnology] is valued at $1.13M. ROIV’s [@Biotechnology] market capitalization is $7.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RGBP’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • RGBP’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, RGBP is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RGBP’s TA Score shows that 1 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • RGBP’s TA Score: 1 bullish, 6 bearish.
  • ROIV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than RGBP.

Price Growth

RGBP (@Biotechnology) experienced а +11.37% price change this week, while ROIV (@Biotechnology) price change was -3.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.15%. For the same industry, the average monthly price growth was +33.42%, and the average quarterly price growth was +4.05%.

Reported Earning Dates

RGBP is expected to report earnings on May 16, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+7.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.44B) has a higher market cap than RGBP($1.13M). ROIV YTD gains are higher at: -7.270 vs. RGBP (-25.164). RGBP has higher annual earnings (EBITDA): -804.74K vs. ROIV (-1.1B). ROIV has more cash in the bank: 4.89B vs. RGBP (1.76K). RGBP has less debt than ROIV: RGBP (968K) vs ROIV (100M). ROIV has higher revenues than RGBP: ROIV (29.1M) vs RGBP (237K).
RGBPROIVRGBP / ROIV
Capitalization1.13M7.44B0%
EBITDA-804.74K-1.1B0%
Gain YTD-25.164-7.270346%
P/E RatioN/A1.97-
Revenue237K29.1M1%
Total Cash1.76K4.89B0%
Total Debt968K100M1%
FUNDAMENTALS RATINGS
RGBP: Fundamental Ratings
RGBP
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RGBPROIV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
N/A
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
RGBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OSBC18.900.56
+3.05%
Old Second Bancorp
TSAT25.680.69
+2.76%
Telesat Corp
BTBD1.370.01
+1.11%
BT Brands
WSO456.550.96
+0.21%
Watsco
AVA38.10-0.27
-0.70%
Avista Corp

RGBP and

Correlation & Price change

A.I.dvisor tells us that RGBP and SABS have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RGBP and SABS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGBP
1D Price
Change %
RGBP100%
-2.03%
SABS - RGBP
23%
Poorly correlated
N/A
ASPHF - RGBP
8%
Poorly correlated
N/A
SHJBF - RGBP
8%
Poorly correlated
N/A
ROIV - RGBP
5%
Poorly correlated
+0.27%
AKESF - RGBP
4%
Poorly correlated
N/A
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+0.27%
IMVT - ROIV
61%
Loosely correlated
+4.09%
ACLX - ROIV
52%
Loosely correlated
+2.55%
CRNX - ROIV
51%
Loosely correlated
+2.40%
KRYS - ROIV
51%
Loosely correlated
+1.69%
CGON - ROIV
50%
Loosely correlated
+1.25%
More